dwp16001
Showing 1 - 14 of 14
Healthy Trial in Chungbuk (DWP16001)
Recruiting
- Healthy
- DWP16001
-
Chungbuk, Korea, Republic ofChungbuk National University Hospital
Apr 3, 2023
Diabetes, Type 2 Trial (DWP16001)
Not yet recruiting
- Diabetes Mellitus, Type 2
- DWP16001
- (no location specified)
Feb 17, 2023
Healthy Trial (DWP16001, DWC202204+DWC202205, DWP16001+DWC202204+DWC202205)
Not yet recruiting
- Healthy
- DWP16001
- +2 more
- (no location specified)
Aug 12, 2022
T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001)
Completed
- T2DM (Type 2 Diabetes Mellitus)
- DWP16001
-
Seoul, Korea, Republic ofDaewoong pharmatceutical
Oct 23, 2022
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)
Not yet recruiting
- Diabetes Mellitus
- +4 more
- DWP16001
- Dapagliflozin Tablet
- (no location specified)
Aug 16, 2022
FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)
Recruiting
- FDC
- Diabetes Mellitus, Type 2
- DWC202213
- +2 more
-
Cheongju-si, Seowon-gu, Korea, Republic ofChungbuk National University Hospital
Feb 10, 2023
Healthy Volunteers Trial in Seoul (DWP16001, DWP202010)
Enrolling by invitation
- Healthy Volunteers
- DWP16001
- DWP202010
-
Seoul, Korea, Republic ofYonsei University Severance Hospital
Apr 4, 2022
Healthy Trial (DWP16001)
Not yet recruiting
- Healthy
- DWP16001
- (no location specified)
Jan 12, 2022
T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001)
Enrolling by invitation
- T2DM (Type 2 Diabetes Mellitus)
- DWP16001
-
Seoul, Korea, Republic ofDaewoong pharmatceutical
Nov 12, 2020
Healthy Trial in Seoul (DWP16001, DWC202001+DWC202002, DWP16001+DWC202001+DWC202002)
Unknown status
- Healthy
- DWP16001
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 23, 2020
Healthy Trial in Seoul (DWP16001, Metformin IR, DWP16001+Metformin IR)
Completed
- Healthy
- DWP16001
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 8, 2020
Type2 Diabetes Trial (DWP16001)
Unknown status
- Type2 Diabetes
- DWP16001
- (no location specified)
Jan 6, 2020
Healthy Trial in Seoul (DWP16001, Placebo, Dapagliflozin)
Completed
- Healthy
- DWP16001
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 19, 2019
T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001, Placebo)
Unknown status
- T2DM (Type 2 Diabetes Mellitus)
- DWP16001
- Placebo
-
Seoul, Korea, Republic ofDaewoong pharmatceutical
Jul 16, 2019